What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.
Each number has its full source under its own list below.
2 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.
Reason: Failed Impurities/Degradation Specifications: Out-of-specification test results.
Reason: Superpotent drug: Assay results were slightly above specification at the time zero point.
Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.
16 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.
Reason: It was confirmed that the impacted lot has a higher occurrence of invalid rates when compared to the product Instructions for Use.
Reason: Due to required inspections not being performed on products/units that have gone through servicing.
Reason: Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result)
Reason: There were reports of an increase in reactive negative controls and false positive results.
Reason: There were reports of an increase in reactive negative controls and false positive results.
Reason: The impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Reason: the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Reason: The RSV target may give a late Ct value and could potentially not pass QC.
Reason: SARS-CoV-2/Flu A/B/RSV Assay Kit may erroneously produce SARS-CoV-2 false positive results.
Reason: The DNA fragments for this specific lot number are too large, resulting in potential background around the cells due to suboptimal hybridization. An absence of signal could also be observed as a resu…
Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.
57 devices cleared (since 1 Jan 2023). Devices the FDA cleared to sell in the US, newest first.
Company: Cepheid®
Company: Nuclein, LLC
Company: Cepheid®
Company: Centers for Disease Control and Prevention
Company: Baebies, Inc.
Company: Ortho Clinical Diagnostics Inc. (QuidelOrtho)
Company: Abbott Diagnostics Scarborough, Inc.
Company: ACON Laboratories, Inc.
Company: Visby Medical, Inc.
Source: openFDA, Premarket notifications (510(k)) cleared, since 1 Jan 2023. Retrieved 12 Nov 2026.
11,634 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.
Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.
Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report Public HealthWorldwide · 2024–2034
View reportAcuitas market sizes and forecasts are only in our full reports. How we use public data.